tiprankstipranks
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market
Holding ACUR?
Track your performance easily

Acura Pharmaceuticals (ACUR) Financial Statements

79 Followers

Acura Pharmaceuticals Financial Overview

Acura Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Acura Pharmaceuticals is scheduled to report earnings on November 14, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Sep 21Jun 21Mar 21Dec 20
Income Statement-
Total Revenue$ 36.00K$ 270.00K$ 613.00K$ 644.00K$ 718.00K
Gross Profit$ 36.00K$ 270.00K$ 613.00K$ 644.00K$ 718.00K
EBIT$ 29.00K$ -262.00K$ -300.00K$ -146.00K$ -131.00K
EBITDA$ 56.00K$ -235.00K$ -282.00K$ -128.00K$ -112.00K
Net Income Common Stockholders$ 29.00K$ -262.00K$ -387.00K$ -259.00K$ -243.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.00K$ 89.00K$ 167.00K$ 361.00K$ 413.00K
Total Assets$ 860.00K$ 1.41M$ 1.90M$ 1.92M$ 1.74M
Total Debt$ 50.00K$ 58.00K$ 230.00K$ 6.16M$ 6.16M
Net Debt$ -15.00K$ -31.00K$ 63.00K$ 5.80M$ 5.75M
Total Liabilities$ 682.00K$ 1.27M$ 1.51M$ 8.05M$ 7.63M
Stockholders Equity$ 178.00K$ 135.00K$ 382.00K$ -6.14M$ -5.89M
Cash Flow-
Free Cash Flow$ -426.00K$ 191.00K$ -194.00K$ -313.00K$ -80.00K
Operating Cash Flow$ -426.00K$ 191.00K$ -194.00K$ -313.00K$ -80.00K
Investing Cash Flow-----
Financing Cash Flow$ 402.00K$ -269.00K-$ 261.00K-
Currency in USD

Acura Pharmaceuticals Earnings and Revenue History

Acura Pharmaceuticals Debt to Assets

Acura Pharmaceuticals Cash Flow

Acura Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis